Helen Thomas
St Vincent's Institute, VIC, Australia
- This delegate is presenting an abstract at this event.
- Scientist
Helen Thomas is a Senior Research Fellow at St Vincent’s Institute in Melbourne. She is head of the Immunology and Diabetes Unit. Her research is focussed on prevention of pancreatic beta cell destruction and identifying the pathways of beta cell death in type 1 and type 2 diabetes. In type 1 diabetes, her research aims to understand and prevent the interaction between beta cells and immune cells. In type 2 diabetes, she is interested in the stress and cell death pathways activated by high glucose concentrations, and testing the role of these pathways in vivo. Her work is being applied to humans through the transplantation of human islets isolated from organ donors by the Tom Mandel Islet Transplant Program in Victoria to reverse type 1 diabetes in severe cases.
Presentations this author is a contributor to:
Dissecting the cytokine responses required for pathogenesis of autoimmune diabetes (#364)
12:00 PM
Helen Thomas
ADS Basic Symposium: Cytokines
Loss of Beta Cell Heparan Sulfate (Hs) is a More Sensitive Marker of T1d Progression in Humans Than Insulin or Heparan Sulfate Proteoglycan (Hspg) Core Protein Content (#224)
2:00 PM
Charmaine Simeonovic
ADS Basic Poster Discussions - Beta cells and glucose control
Generating a transcript, microRNA and epigenome map of insulin-producing cells (#222)
2:00 PM
Wilson Wong
ADS Basic Poster Discussions - Beta cells and glucose control
Human Islet-derived Progenitor Cells regulate T-cell proliferation via exosomal transfer of microRNAs (#102)
8:45 AM
Mugdha Joglekar
ADS Basic Orals: Beta Cells